Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The Board found the Company and its promoters/directors guilty of extensive violations spanning FYs 2014-15 to 2019-20, including misstatements in financial statements, improper accounting treatments, and disclosure violations designed to defraud investors. Key violations included incorrect impairment accounting under Ind AS 36, improper capitalization of R&D costs violating AS 26/Ind AS 38, false shareholding pattern disclosures, misleading press releases, inadequate audit coverage of subsidiaries, and non-compliance with GDPR disclosure requirements. The Board imposed market access restrictions on all parties for specified periods, with promoters facing additional directorship bars. The Company must file impact statements with stock exchanges and publish subsidiary financial statements. Monetary penalties were levied against all parties, with promoters receiving higher penalties given their direct benefit from the fraudulent scheme.
The Board found the Company and its promoters/directors guilty of extensive violations spanning FYs 2014-15 to 2019-20, including misstatements in financial statements, improper accounting treatments, and disclosure violations designed to defraud investors. Key violations included incorrect impairment accounting under Ind AS 36, improper capitalization of R&D costs violating AS 26/Ind AS 38, false shareholding pattern disclosures, misleading press releases, inadequate audit coverage of subsidiaries, and non-compliance with GDPR disclosure requirements. The Board imposed market access restrictions on all parties for specified periods, with promoters facing additional directorship bars. The Company must file impact statements with stock exchanges and publish subsidiary financial statements. Monetary penalties were levied against all parties, with promoters receiving higher penalties given their direct benefit from the fraudulent scheme.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4828 
Join Channel 
